News

TipRanks on MSN22h

Eli Lilly’s Promising Study on Baricitinib for Juvenile Arthritis: A Market Game-Changer?

Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is ...
TipRanks on MSN22h

Eli Lilly’s Mirikizumab Study: A Promising Step for Pediatric Ulcerative Colitis Treatment

Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Eli Lilly and Company is conducting a ...
TipRanks on MSN22h

Eli Lilly’s Promising Cancer Therapy Study: A Potential Game-Changer?

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Greenwich Time20h

Connecticut city sues drugmakers, pharmacy benefit managers over insulin cost

The lawsuit alleges civil violations of the Racketeer Influenced and Corrupt Organizations Act, or RICO, the Connecticut ...
North Carolina Health News6h

Kennedy’s anti-vaccine strategy risks forcing shots off market, manufacturers warn

Robert F. Kennedy Jr.’s leadership at HHS sparks controversy as his vaccine agenda reshapes policy, regulation, and public health.